These phenotypes are consistent with the heightened response to TLR7/8 and TLR9 pathways we observed in healthy Black control samples and are the same immune subsets altered during heightened disease in Black patients with SLE. The gene discussed is TLR7; the disease is systemic lupus erythematosus.